|
RGS1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.477600E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.899630E-01 |
| Normal-vs-Stage2 |
3.941200E-03 |
| Normal-vs-Stage3 |
1.046370E-01 |
| Normal-vs-Stage4 |
4.861600E-02 |
| Stage1-vs-Stage2 |
1.64639999999938E-06 |
| Stage1-vs-Stage3 |
3.926000E-01 |
| Stage1-vs-Stage4 |
7.330300E-02 |
| Stage2-vs-Stage3 |
2.460200E-03 |
| Stage2-vs-Stage4 |
2.742500E-02 |
| Stage3-vs-Stage4 |
4.398600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.694820E-01 |
| Normal-vs-AfricanAmerican |
2.052400E-01 |
| Normal-vs-Asian |
7.882400E-03 |
| Caucasian-vs-AfricanAmerican |
8.778600E-01 |
| Caucasian-vs-Asian |
1.74908999999168E-05 |
| AfricanAmerican-vs-Asian |
8.550200E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.957700E-02 |
| Normal-vs-Female |
1.125570E-01 |
| Male-vs-Female |
4.139200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.469000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.577700E-02 |
| Normal-vs-Age(61-80Yrs) |
3.775600E-02 |
| Normal-vs-Age(81-100Yrs) |
7.987600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.603700E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.244460E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.022400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.735600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.685000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.906220E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.471000E-01 |
| Classical-VS-Follicular |
2.657600E-02 |
| Classical-VS-Other |
9.377400E-01 |
| Classical-VS-Normal |
1.384380E-01 |
| Tall-VS-Follicular |
3.303000E-01 |
| Tall-VS-Other |
5.723400E-01 |
| Tall-VS-Normal |
7.301900E-02 |
| Follicular-VS-Other |
4.096400E-01 |
| Follicular-VS-Normal |
2.208500E-02 |
| Other-VS-Normal |
3.080600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.487800E-02 |
| Normal-vs-N1 |
2.959800E-01 |
| N0-vs-N1 |
2.267200E-01 |
|
|
